[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100370114":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":13,"locations":18,"responsibleParty":34,"collaborators":7,"id":37,"slug":7,"hasResults":38,"nctId":39,"briefTitle":40,"officialTitle":41,"acronym":42,"eligibilityCriteria":43,"healthyVolunteers":38,"sex":44,"minAge":45,"maxAge":7,"enrollmentInfo":46,"targetDuration":49,"studyType":50,"phases":7,"briefSummary":51,"conditions":52,"keywords":7,"overallStatus":21,"whyStopped":7,"lastUpdateSubmitDate":55,"lastUpdatePostDateStruct":56,"startDateStruct":59,"completionDateStruct":61,"leadSponsor":63,"locationsCount":64},{"fullName":5,"class":6},"University of Ulm","OTHER",null,[9],{"name":10,"affiliation":11,"role":12},"Thomas Seufferlein, MD","Ulm University Hospital","PRINCIPAL_INVESTIGATOR",[14],{"name":10,"role":15,"phone":16,"phoneExt":7,"email":17},"CONTACT","+49 731 50044501","thomas.seufferlein@uniklinik-ulm.de",[19],{"facility":20,"status":21,"city":22,"state":7,"zip":7,"country":23,"countryCode":24,"cosmosGeoPoint":25,"geoPoint":30,"contacts":31},"Universitätsklinikum Ulm","RECRUITING","Ulm","Germany","DE",{"type":26,"coordinates":27},"Point",[28,29],9.99155,48.39841,{"lat":29,"lon":28},[32],{"name":10,"role":15,"phone":33,"phoneExt":7,"email":17},"0049-731-500-44501",{"type":12,"investigatorFullName":35,"investigatorTitle":36,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"Thomas Seufferlein","Head of department for internal medicine I","100370114",false,"NCT04099134","PACAREG: a Multicenter Registry Trial in Pancreatic Ductal Adencarcinoma","PaCaReg: A Multicenter Registry Trial for the Assessement of Clinical, Epidemiological and Biological Profiles in Patients With Pancreatic Ductal Adenocarcinoma","PaCaReg","Inclusion Criteria:\n\n* Treatment naive histologically or cytologically proven pancreatic ductal adenocarcinoma (PDAC) or highly suspicious diagnosis (only pre-curative-intended resection)\n* Age =\\>18 years\n* written informed consent\n\nExclusion Criteria:\n\n* papillary cancer\n* neuroendocrine pancreatic tumors","ALL","18 Years",{"count":47,"type":48},5000,"ESTIMATED","10 Years","OBSERVATIONAL","PaCaReg is a multicenter registry trial aiming in the assessement of clinical, epidemiological and biological profiles in patients with pancreatic ductal adenocarcinoma",[53,54],"Pancreas Adenocarcinoma","Pancreas Cancer","2019-09-23",{"date":57,"type":58},"2019-09-25","ACTUAL",{"date":60,"type":58},"2018-10-10",{"date":62,"type":48},"2029-10",{"name":5,"class":6},1]